Discover a wide selection of preclinical services to accelerate your drug development
Oncodesign Services is a contract research organization (CRO) with over 25 years of experience in drug discovery and preclinical services, in the key therapeutic areas: oncology, inflammation and infectious diseases.
We contribute to the development of innovative therapies against diseases with high medical needs.
To progress your program from target identification to IND
We offer experimented services which cover the early drug discovery and preclinical research journey, from early phases of hit finding, hit-to-lead, lead optimization to IND enabling studies.
The key objective of Lead Optimization (LO) is to improve the pharmacological profile and DMPK properties of the Lead compound, such as efficacy, safety, pharmacokinetics and pharmacodynamics, to make it suitable for development into a drug candidate.
Who is Oncodesign Services?
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. From target identification to IND filing, the company contributes to the development of innovative therapies in oncology, inflammation and infectious diseases, with high medical needs.
Oncodesign Services has 230 employees in France, Canada and the United States.